SCHEMBL356572

SCHEMBL356572

C[C@H](N)C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.34
KMT2A Q03164 1/20 0.30
ATM Q13315 1/20 0.30
DPP4 P27487 1/20 0.30
DPP8 Q6V1X1 1/20 0.30
DPP9 Q86TI2 1/20 0.30
ACE P12821 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13061953 1.00 MGLL (0.34) MGLLKMT2AATMDPP4DPP8
SCHEMBL10869514 1.00 MGLL (0.34) MGLLKMT2AATMDPP4DPP8
SCHEMBL8478185 0.85 SLC7A5 (0.35) MGLLDPP4
SCHEMBL5615330 0.85 SLC7A5 (0.35) MGLLDPP4
SCHEMBL24576662 0.85 SLC7A5 (0.35) MGLLDPP4
SCHEMBL17430432 0.83 MGLL (0.36) MGLLKMT2AATM
SCHEMBL258692 0.83 MGLL (0.36) MGLLKMT2AATM
SCHEMBL13551294 0.82 MGLL (0.35) MGLLKMT2AATM
SCHEMBL18908274 0.82 MGLL (0.35) MGLLKMT2AATM
SCHEMBL17762751 0.81 DPP4 (0.36) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049180-A1 FAST CURING, STICKY POLYMERS FOR MEDICAL USES UNIV CALIFORNIA (US) 2026-02-19 US claimed
US-12269925-B1 Fast curing, biocompatible and biodegradable adhesives and sealants THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-04-08 US claimed
CN-116041441-A Synthesis method of daptomycin 申联生物医药(上海)股份有限公司 2023-05-02 CN claimed
US-20260049180-A1 FAST CURING, STICKY POLYMERS FOR MEDICAL USES UNIV CALIFORNIA (US) 2026-02-19 US disclosed
US-12269925-B1 Fast curing, biocompatible and biodegradable adhesives and sealants THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-04-08 US disclosed
CN-116829949-A Compositions for detecting or measuring analytes 伯蒂斯有限公司 2023-09-29 CN disclosed
CN-116041441-A Synthesis method of daptomycin 申联生物医药(上海)股份有限公司 2023-05-02 CN disclosed
CN-108463728-B Isobaric and ectopic mass marker 电泳有限公司 2023-03-24 CN disclosed
US-20210332047-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORP (US) 2021-10-28 US disclosed
US-9678083-B2 Protected amine labels and use in detecting analytes DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-06-13 US disclosed
EP-2488492-B1 PROTECTED AMINE LABELS AND USE IN DETECTING ANALYTES DANA FARBER CANCER INST INC (US) 2016-01-13 EP disclosed
US-20120258886-A1 PROTECTED AMINE LABELS AND USE IN DETECTING ANALYTES DANA-FARBER CANCER INSTITUTE, INC. (US) 2012-10-11 US disclosed
EP-2488492-A2 PROTECTED AMINE LABELS AND USE IN DETECTING ANALYTES Dana-Farber Cancer Institute, Inc. (US) 2012-08-22 EP disclosed
US-20120015964-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2012-01-19 US disclosed
WO-2011088423-A2 ISOBARIC TAGS FOR ANALYTE DETECTION AND QUANTIFICATION CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2011-07-21 WO disclosed
WO-2011047192-A2 PROTECTED AMINE LABELS AND USE IN DETECTING ANALYTES DANA-FARBER CANCER INSTITUTE, INC. (US) 2011-04-21 WO disclosed
EP-1761540-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2007-03-14 EP disclosed
WO-2005113556-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2005-12-01 WO disclosed
EP-0674623-A1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1995-10-04 EP disclosed
WO-1994014776-A2 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1994-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015964-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA PIK3CD, PIK3CA, PI4KA MGLL 2480/4885KMT2A 3934/4885ATM 572/4885
US-20120258886-A1 PROTECTED AMINE LABELS AND USE IN DETECTING ANALYTES SRMS, AADAT, AANAT MGLL 3913/4885KMT2A 786/4885ATM 2099/4885
US-20260049180-A1 FAST CURING, STICKY POLYMERS FOR MEDICAL USES ILK, VCL, PTK2 MGLL 494/4885KMT2A 1951/4885ATM 495/4885
US-20210332047-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA PIK3CD, PIK3CA, PI4KA MGLL 2480/4885KMT2A 3934/4885ATM 572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.